1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Metastatic Solid Neoplasm: new trials by email Literature Review of Metastatic Solid Neoplasm trials Research Report on Metastatic Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants SYNB1891, Atezolizumab - Metastatic Solid Neoplasm, Lymphoma | Phase 1 | Terminated | Synlogic | 32 | 2019-12-12 | 2024-05-03 |
| APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery Laboratory Biomarker Analysis, siRNA-transfected Peripheral Blood Mononuclear Cells (PBMC) APN401 - Metastatic Malignant Neoplasm in the Brain, Metastatic Solid Neoplasm | Phase 1 | Completed | Wake Forest University Health Sciences | 11 | 2017-04-28 | 2024-10-10 |
Neoplasm Metastasis (2) · Brain Neoplasms (1) · Colorectal Neoplasms (1) · Lymphoma (1) · Pancreatic Neoplasms (1)
Neoplasms (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Hemic and Lymphatic Diseases (1)
atezolizumab (1)
Synlogic (1) · Wake Forest University Health Sciences (1)
United States (2)
Aoife Brennan, MB, BCh, BAO, MMSc (1) · Pierre Triozzi (1)
P30CA012197 (1)